Hande Bulut Canbaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hande Bulut Canbaz has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Havva Sezer
Koc Univ, Dept Endocrinol & Metab, Fac Med, Istanbul, Turkey
4 shared publications - Dilek Yazici
Department of Endocrinology and Metabolism, Koc University Faculty of Medicine, Istanbul, Turkey
3 shared publications - Aslihan Yerlikaya
Koc University School of Medicine, Istanbul, Turkey
1 shared publication Aslıhan Yerlikaya
Department of Internal Medicine, Yale New Haven Health Bridgeport Hospital, USA
1 shared publication- Bahar Bekdemir
Koc Univ, Fac Nursing, Istanbul, Turkey
1 shared publication - Baris Ata
ART Fertility Clinics, Dubai, United Arab Emirates; Department of Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkiye
1 shared publication
Latest Publications
- Open Access
- 11 June 2025
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
- Vol. 29 (3) , 223-228
Frequency and Characteristics of Antibody Negative Chronic Thyroiditis: An Experience from a Tertiary Center
Objective: Limited literature is relevant to antibody-negative chronic thyroiditis (AN-CT). The aim was to investigate the frequency and characteristics of AN-CT and explore the presence of other autoim mune and autoinflammatory diseases in patients with AN-CT. Methods: Consecutive participants in the follow-up above 18 years old diagnosed with hypothyroid ism caused by chronic thyroiditis (CT) between December 2016 and March 2024 were included in the study. A total of 767 euthyroid patients with CT under levothyroxine (LT4) treatment were analyzed retrospectively. The patient group was divided into 2 subgroups: antibody-negative and antibody positive. Characteristics and comorbid conditions were compared between the 2 groups. Results: There were 582 patients (75.9%) with classic Hashimoto’s thyroiditis (antibody-positive) and 185 patients (24.1%) with AN-CT in the study group. The female/male ratio was similar in the 2 groups (P = .730). The median body mass index was comparable between the 2 groups (P = .486). Median age (P = .003) and thyroid nodule frequency (P = .011) were significantly higher in the AN-CT group. The duration of hypothyroidism was shorter (P = .022), and the daily LT4 dose to achieve euthyroidism was lower (P < .001) in patients with AN-CT. The presence of other autoimmune and autoinflammatory diseases did not differ between the 2 groups. Conclusion: In this study group, AN-CT frequency was 24.1%. Older age, shorter duration of hypo thyroidism, higher thyroid nodule frequency, and lower daily LT4 dose to achieve euthyroidism were associated with AN-CT. However, patients with AN-CT had similar behavior relevant to other autoim mune and autoinflammatory disorders when compared with Hashimoto’s patients. Cite this article as: Sezer H, Canbaz HB. Frequency and characteristics of antibody negative chronic thyroiditis: an experience from a tertiary center. Endocrinol Res Pract. 2025;29(3):223-228.
- 11 June 2025
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
- Vol. 29 (3) , 223-228
Open AccessFrequency and Characteristics of Antibody Negative Chronic Thyroiditis: An Experience from a Tertiary Center
Objective: Limited literature is relevant to antibody-negative chronic thyroiditis (AN-CT). The aim was to investigate the frequency and characteristics of AN-CT and explore the presence of other autoim mune and autoinflammatory diseases in patients with AN-CT. Methods: Consecutive participants in the follow-up above 18 years old diagnosed with hypothyroid ism caused by chronic thyroiditis (CT) between December 2016 and March 2024 were included in the study. A total of 767 euthyroid patients with CT under levothyroxine (LT4) treatment were analyzed retrospectively. The patient group was divided into 2 subgroups: antibody-negative and antibody positive. Characteristics and comorbid conditions were compared between the 2 groups. Results: There were 582 patients (75.9%) with classic Hashimoto’s thyroiditis (antibody-positive) and 185 patients (24.1%) with AN-CT in the study group. The female/male ratio was similar in the 2 groups (P = .730). The median body mass index was comparable between the 2 groups (P = .486). Median age (P = .003) and thyroid nodule frequency (P = .011) were significantly higher in the AN-CT group. The duration of hypothyroidism was shorter (P = .022), and the daily LT4 dose to achieve euthyroidism was lower (P < .001) in patients with AN-CT. The presence of other autoimmune and autoinflammatory diseases did not differ between the 2 groups. Conclusion: In this study group, AN-CT frequency was 24.1%. Older age, shorter duration of hypo thyroidism, higher thyroid nodule frequency, and lower daily LT4 dose to achieve euthyroidism were associated with AN-CT. However, patients with AN-CT had similar behavior relevant to other autoim mune and autoinflammatory disorders when compared with Hashimoto’s patients. Cite this article as: Sezer H, Canbaz HB. Frequency and characteristics of antibody negative chronic thyroiditis: an experience from a tertiary center. Endocrinol Res Pract. 2025;29(3):223-228.
- 13 June 2023
- Published by SAGE Publications in The American Surgeon™
- Vol. 89 (12) , 5996-6004
Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer
Aim: The aims of the study are to evaluate the predictive value of early post-operative stimulated thyroglobulin (sTg) analysis on the recurrence risk, and to define a cut-off value that is related to recurrence risk in low to intermediate risk papillary thyroid cancer (PTC). Methods: This retrospective cohort study included individuals who were diagnosed with PTC aged 18 years or older and had been operated by experienced surgeons of a tertiary university hospital between the years 2011 and 2021. The American Thyroid Association thyroid cancer guidelines version 2015 was used as the risk stratification system. Early sTg measurement obtained at 3-4 weeks after surgery when TSH >30 µIU/mL. Data was collected from the hospital database. A total of 328 patients who had post-operative early sTg values with negative anti-Tg antibodies were included. Results: The median age was 44 years. Of the 328 patients, 223 (68%) were women. The median tumor diameter was 11 mm. One hundred ninety-one patients (58.2%) had low risk and 137 (41.8%) had intermediate risk for recurrent disease. Of the 328 patients, 4.0% had recurrent disease. In multivariate Cox regression, post-operative early sTg value [OR: 1.070 (1.038-1.116), P = .000], and the pre-operative malign cytology [OR: 1.483 (1.080-2.245), P = .042] were independent risk factors for recurrence. On the ROC curve analysis, the cut-off value of early sTg was 4.1 ng/mL for those with recurrent disease. Conclusion: This study demonstrated that early sTg could predict recurrent disease in patients with low to intermediate risk PTC. A cut-off of 4.1 ng/mL was identified with a high negative predictive value.
- 13 June 2023
- Published by SAGE Publications in The American Surgeon™
- Vol. 89 (12) , 5996-6004
Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer
Aim: The aims of the study are to evaluate the predictive value of early post-operative stimulated thyroglobulin (sTg) analysis on the recurrence risk, and to define a cut-off value that is related to recurrence risk in low to intermediate risk papillary thyroid cancer (PTC). Methods: This retrospective cohort study included individuals who were diagnosed with PTC aged 18 years or older and had been operated by experienced surgeons of a tertiary university hospital between the years 2011 and 2021. The American Thyroid Association thyroid cancer guidelines version 2015 was used as the risk stratification system. Early sTg measurement obtained at 3-4 weeks after surgery when TSH >30 µIU/mL. Data was collected from the hospital database. A total of 328 patients who had post-operative early sTg values with negative anti-Tg antibodies were included. Results: The median age was 44 years. Of the 328 patients, 223 (68%) were women. The median tumor diameter was 11 mm. One hundred ninety-one patients (58.2%) had low risk and 137 (41.8%) had intermediate risk for recurrent disease. Of the 328 patients, 4.0% had recurrent disease. In multivariate Cox regression, post-operative early sTg value [OR: 1.070 (1.038-1.116), P = .000], and the pre-operative malign cytology [OR: 1.483 (1.080-2.245), P = .042] were independent risk factors for recurrence. On the ROC curve analysis, the cut-off value of early sTg was 4.1 ng/mL for those with recurrent disease. Conclusion: This study demonstrated that early sTg could predict recurrent disease in patients with low to intermediate risk PTC. A cut-off of 4.1 ng/mL was identified with a high negative predictive value.
- Open Access
- 1 July 2022
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 23 (4) , 268-276
Is obesity paradox valid for critically-ill COVID-19 patients with respiratory failure?
Body mass index,acute respiratory distress syndrome,COVID-19,obesity paradox,mortality
- 1 July 2022
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 23 (4) , 268-276
Open AccessIs obesity paradox valid for critically-ill COVID-19 patients with respiratory failure?
Body mass index,acute respiratory distress syndrome,COVID-19,obesity paradox,mortality
- Open Access
- 1 January 2021
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 9 (2) , 140-148
The Frequency of Acceptance of Oral Glucose Tolerance Test in Turkish Pregnant Women: a single tertiary center results
OBJECTIVE: It is thought that there is not enough data about the frequency of acceptance of oral glucose tolerance test (OGTT) in Turkish pregnant women. The aim of this study was to investigate the frequency of acceptance of OGTT among participants in our single tertiary center. METHODS: The data of non-diabetic 344 pregnant women seen at the Obstetrics Clinic of our hospital between September 2016 and September 2017 were obtained from the hospital records. Women who did not have regular follow-up during pregnancy were excluded. One of the two or one-step approaches was used in the diagnosis of gestational diabetes mellitus (GDM) depending on the choice of the physician following the patient. RESULTS: There were 223 subjects eligible for the study. One hundred seventy-seven pregnant women (79.4%) accepted to do OGTT. We determined that 46 women (20.6%) did not complete at least one OGTT, of whom 74% (n=34) never completed the recommended screening test in this cohort. The overall frequency of GDM was approximately 15.2% (n=34). OGTT acceptability was higher among pregnant women with university graduates (p=0.02). Adverse pregnancy outcomes were similar between the accepted and rejected groups. Among the reasons for OGTT rejection, the media had a significant influence (n=35). CONCLUSION: Our results show that a significant percentage of patients refused to do OGTT. Therefore the actual frequency of pregnant women with GDM could not be determined. One way to increase compliance may be recommending only the one-step test for pregnant women in countries with a high rejection rate of OGTT.
- 1 January 2021
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 9 (2) , 140-148
Open AccessThe Frequency of Acceptance of Oral Glucose Tolerance Test in Turkish Pregnant Women: a single tertiary center results
OBJECTIVE: It is thought that there is not enough data about the frequency of acceptance of oral glucose tolerance test (OGTT) in Turkish pregnant women. The aim of this study was to investigate the frequency of acceptance of OGTT among participants in our single tertiary center. METHODS: The data of non-diabetic 344 pregnant women seen at the Obstetrics Clinic of our hospital between September 2016 and September 2017 were obtained from the hospital records. Women who did not have regular follow-up during pregnancy were excluded. One of the two or one-step approaches was used in the diagnosis of gestational diabetes mellitus (GDM) depending on the choice of the physician following the patient. RESULTS: There were 223 subjects eligible for the study. One hundred seventy-seven pregnant women (79.4%) accepted to do OGTT. We determined that 46 women (20.6%) did not complete at least one OGTT, of whom 74% (n=34) never completed the recommended screening test in this cohort. The overall frequency of GDM was approximately 15.2% (n=34). OGTT acceptability was higher among pregnant women with university graduates (p=0.02). Adverse pregnancy outcomes were similar between the accepted and rejected groups. Among the reasons for OGTT rejection, the media had a significant influence (n=35). CONCLUSION: Our results show that a significant percentage of patients refused to do OGTT. Therefore the actual frequency of pregnant women with GDM could not be determined. One way to increase compliance may be recommending only the one-step test for pregnant women in countries with a high rejection rate of OGTT.